Triclabendazole
From Wikipedia, the free encyclopedia
 |
|
|
Triclabendazole
|
|
| Systematic (IUPAC) name | |
| 5-chloro-6- (2,3-dichlorophenoxy) -2-methylsulfanyl- 3H-benzoimidazole | |
| Identifiers | |
| CAS number | |
| ATC code | P02 |
| PubChem | |
| Chemical data | |
| Formula | C14H9Cl3N2OS |
| Mol. mass | 359.658 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | oxidation to the sulfone and sulfoxide parent compound |
| Half life | 22 - 24 hs |
| Excretion | >95% in faeces, 2% in urine, and < 1% in milk |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
? |
| Routes | ? |
Triclabendazole (commercial name Fasinex) is a member of the Benzimidazole family of anthelmintics. The benzimidazole drugs share a common molecular structure, triclabendazole being the exception in having a chlorinated benzene ring but no carbamate group.
Triclabendazole displays high efficacy against both immature and adult liver fluke.
It is generally accepted that benzimidazoles like triclabendazole bind to beta-tubulin and prevent the polymerisation of the microtubules of which they are part.
[edit] External links
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 |
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
